by admin_63069 | Dec 16, 2024 | News You Can Use
A study’s implications for veteran access to prostate cancer treatments
by admin_63069 | Dec 9, 2024 | News You Can Use
Recent approvals, emerging therapies, and future directions
by admin_63069 | Dec 2, 2024 | News You Can Use
The trial excluded patients with recent chemotherapy, immunotherapy, or major surgeries, ensuring a focused study population.
by admin_63069 | Nov 18, 2024 | News You Can Use
VA analysis finds men with limited life expectancy still getting aggressive treatment.
by admin_63069 | Oct 9, 2024 | News You Can Use
Patients with metastatic, castration-resistant prostate cancer saw significant benefits from the combination of Xofigo and Xtandi.
